PDA Announces 2008 Board of Directors and Officers
The Parenteral Drug Association (PDA, Bethesda, MD) has announced its 2008 board of directors and officers.
The Parenteral Drug Association (PDA, Bethesda, MD), has announced its 2008 board of directors and officers.
The newly elected officers for 2008–2009 are: Chair, John Shabushnig, Pfizer Inc.; Chair-Elect, Maik Jornitz, Sartorius Stedim Biotech; Secretary, Rebecca Devine, Regulatory Consultant; and Treasurer, Anders Vinther, Genentech, Inc. The 2006–2007 Chair, Vincent Anicetti, Genentech, Inc., assumes the office of Immediate Past Chair.
Laura Thoma, University of Tennesee, was reelected for a second term as a director. In addition, there are five new directors joining PDA’s board, including: Harold Baseman, ValSource LLC; Véronique Davoust, Pfizer Inc.; Lothar Hartmann, Hoffman-La Roche; Stefan Köhler, AstraZeneca; and Michael Sadowski, Baxter Healthcare Corporation.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
